2021 SITC Poster

November 13, 2021

“KSQ-004: Unbiased Pair-wise Discovery of SOCS1 and Regnase-1 as the Top CRISPR/Cas9 Dual-edit Combination Enhancing in vivo TIL Potency Against Solid Tumors”

© 2024 KSQ Therapeutics, Inc. All rights reserved.